Loading clinical trials...
Loading clinical trials...
This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples. Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice. The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Hospital Infanta Cristina
Madrid, Badajoz, Spain
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital del Mar
Barcelona, Barcelona, Spain
Hospital Universitario Quirón Dexeus
Barcelona, Barcelona, Spain
Hospital Vall d'Hebron
Barcelona, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
Hospital Marques de Valdecilla
Santander, Cantabria, Spain
Hospital Insular de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Ramón y Cajal
Madrid, Madrid, Spain
Hospital Costa del SOl
Marbella, Málaga, Spain
Start Date
April 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
May 5, 2015
58
ACTUAL participants
Lead Sponsor
Grupo Español Multidisciplinar de Melanoma
NCT03154190
NCT03112668
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions